Showing results (161-170 of 201) with videos related to
Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2001
Impact of high-dose chemotherapy on peripheral T-cell lymphomasJ Rodriguez, M Munsell, S Yazji, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignanciesI F Khouri, M Keating, M Körbling, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescueS Giralt, D Weber, M Colome, et al.Bone Marrow Transplantation|October 21, 2000
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's diseaseP Anderlini, S Giralt, B Andersson, et al.British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.British Journal of Haematology|July 27, 2005
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host diseaseD R Couriel, R Saliba, M P Escalón, et al.Blood|February 9, 2000
Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusionsD L Porter, R H Collins, C Hardy, et al.Bone Marrow Transplantation|October 26, 2005
The early referral for reduced-intensity stem cell transplantation in patients with Ph1 (+) chronic myelogenous leukemia in chronic phase in the imatinib era: results of the Latin American Cooperative Oncohematology Group (LACOHG) prospective, multicenter studyG J Ruiz-Argüelles, D Gómez-Almaguer, A Morales-Toquero, et al.Blood|November 24, 2001
The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phaseS J Lee, J P Klein, C Anasetti, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 14, 1997
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?R Storb, W Leisenring, C Anasetti, et al.Pageof 21